paymentsCash Flow (CF) Summary

Updated: 2026/06/30FY2027 Q1

Operating CF

1276.2B JPY

YoY -40.8%

Investing CF

-877B JPY

YoY -164.2%

Financing CF

-1803.5B JPY

YoY +16.1%

Free CF

399.2B JPY

YoY -78.1%

Cash Flow Trend (5 Years)

Investing CF

Operating CF

Financing CF

1.1T0

-1.1T

0000

1.1T

-1981.3億

-1.1T

2022

9771.6億

-6071億

-7091.5億

2023

7163.4億

-4638.6億

-3544.2億

2024

1.1T

-3670.6億

-7514.3億

2025

-3691.4億

-4968.2億

2026

analyticsInvestment Efficiency Analysis

Operating CF vs Investing CF

Operating CF

Investing CF

1.3T6457.9億0-6457.9億-1.3T

20222023202420252026

waterfall_chartCash Flow Bridge (FY2026 Annual)

Beginning / Ending

Increase

Decrease

2T1.5T1T5000億0

4195.8億

Opening Cash

Operating CF

-3691.4億

Investing CF

-4968.2億

Financing CF

Other

5950.5億

Closing Cash

Takeda Pharmaceutical Company Limited

paymentsCash Flow (CF) Summary

Cash Flow Trend (5 Years)

analyticsInvestment Efficiency Analysis

waterfall_chartCash Flow Bridge (FY2026 Annual)

Cash Flow Statement

Unlock Long-Term Financial Data